Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/21555352

Download in:

View as

General Info

PMID
21555352